Pubblicazioni

Obinutuzumab does not improve complete methabolic response but does not compromise mobilization or engraftment of autologous peripheral blood stem cells in diffuse large B cell lymphoma: Results from a fondazione italiana linfomi prospective phase II study (the GIOTTO study)

2022 - HEMATOLOGICAL ONCOLOGY

Rigacci, Luigi; Battistini, Roberta; Kovalchuk, Sofia; Zoli, Valerio; Puccini, Benedetta; Evangelista, Andrea; Arcaini, Luca; Flenghi, Leonardo; Visco, Carlo; Mian, Michael; Di Rocco, Alice; Peracchio, Claudia; Gotti, Manuel; Tisi, Maria Chiara; Palombi, Francesca; Pozzi, Samantha; Gioia, Daniela; Viero, Piera; Martelli, Maurizio

Impact of anti-SARS-CoV-2 monoclonal antibodies in the management of patients with lymphoma and COVID19: A retrospective study

2022 - HEMATOLOGICAL ONCOLOGY

Assanto, G. M.; Di Rocco, A.; Malfona, F.; Capriata, M.; Del Giudice, I.; Petrucci, L.; Girardi, P.; D'Elia, G. M.; Martelli, M.; Gentile, G.; Micozzi, A.; Pulsoni, A.

Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy. results from a monoinstitutional cohort analysis of long-term survivors

2017 - HEMATOLOGICAL ONCOLOGY

De Sanctis, Vitaliana; Alfo', Marco; Di Rocco, Alice; Ansuinelli, Michela; Russo, Eleonora; Osti, Mattia Falchetto; Valeriani, Maurizio; Minniti, Giuseppe; Grapulin, Lavinia; Musio, Daniela; Bracci, Stefano; Spagnoli, Alessandra; Moleti, Maria Luisa; Tombolini, Vincenzo; Martelli, Maurizio